Acute Coronary Syndrome
Non–ST-Elevation Myocardial
Infarction: A Case Study
 |
||
|
How to Obtain AMA PRA
|
|
 |
||
Release Date: July 17, 2009
Renewal Date: July 17, 2010
Expiration Date: July 17, 2011
Estimated Time of Completion: 1 hour
Description
The purpose of this activity is to examine triage to early invasive vs initially conservative management of patients with non-ST-elevation acute coronary syndrome (NSTEMI ACS), including the timing of angiography, an assessment of antithrombotic therapies in terms of selection, dosing, and timing, the role of antiplatelet resistance testing to determine risk of stent thrombosis and ischemic complications, and the potential role of new antiplatelet agents in this setting.
Objectives
At the conclusion of this activity, the participant will be able to:
- Identify which patients benefit from various types of medical and invasive therapies for unstable angina (UA)/NSTEMI.
- Relate how specific diagnostic tools identify patients with UA/STEMI.
- Describe the appropriate use of antiplatelet drugs during treatment for UA/STEMI.
Target Audience
This activity is targeted to physicians who treat patients for coronary artery disease (CAD) or see patients at some point in the course of evaluation for potential UA or myocardial infarction (MI), such as primary care physicians, emergency room physicians, or cardiologists.
Accreditation
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the
Accreditation Council for Continuing Medical Education to provide continuing medical
education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association Council on Continuing Medical Education for Category 2 credit.
Activity DirectorA. Michael Lincoff, MD |
Faculty
Stephen G. Ellis, MD |
Disclosure
In accordance with the Standards for Commercial Support issued by the Accreditation
Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation
Center for Continuing Education requires resolution of all faculty conflicts of interest to
ensure CME activities are free of commercial bias.
The following faculty members have indicated that they have no relationship which, in the context of their presentations, could be perceived as a potential conflict of interest:
A. Michael Lincoff, MD
Stephen G. Ellis, MD
The Cleveland Clinic Foundation Center for Continuing Education acknowledges
educational grants for partial support of this activity from:
Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership
Daiichi Sankyo, Inc. and Eli Lilly and Company
This CME activity was produced by The Cleveland Clinic Foundation
Center for Continuing Education,
The Cleveland Clinic Sydell and Arnold Miller Family Heart & Vascular Institute and DIME.
